Financials
- Market Capitalization 32.86 M
- Employee 162
- Founded 2015
- CEO N/A
- Website www.gossamerbio.com
- Headquarter Delaware, United States
- FIGI BBG00MVWLLM2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4447 | RADX Radiopharm Theranostics Limited American Depositary Shares | 4.33 USD | -0.92% | +2.85% | +2.85% | +1.88% | 34.13 M USD | ||
| 4452 | LSTA Lisata Therapeutics, Inc. - Common Stock | 3.70 USD | +13.15% | +11.11% | +5.11% | +42.86% | 33.69 M USD | ||
| 4461 | BCTX BriaCell Therapeutics Corp. - Common Shares | 3.75 USD | -4.82% | +5.04% | +31.12% | +89.39% | 32.62 M USD | ||
| 4464 | LITS Lite Strategy, Inc. - Common Stock | 0.95 USD | -5.94% | -3.06% | +21.79% | -68.12% | 32.32 M USD |
Frequently asked questions about Gossamer Bio, Inc. - Common Stock
What is the Gossamer Bio, Inc. - Common Stock stock price today?
The current price of Gossamer Bio, Inc. - Common Stock (GOSS) is 0.14. Over the past 24 hours, the stock has changed by -17.65%. Follow the GOSS chart for real-time price dynamics.
What is the stock ticker of Gossamer Bio, Inc. - Common Stock?
Gossamer Bio, Inc. - Common Stock trades under the ticker GOSS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gossamer Bio, Inc. - Common Stock stock going up?
GOSS has changed by -26.32% over the last week, -17.65% over the last month, and -90.91% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Gossamer Bio, Inc. - Common Stock net income for the last quarter?
Gossamer Bio, Inc. - Common Stock reported net income of -46.66 M for the last quarter. The previous quarter showed -47.24 M, which means net income changed by +1.22%.
How many employees does Gossamer Bio, Inc. - Common Stock have?
As of the latest available data, Gossamer Bio, Inc. - Common Stock has 162 employees. Workforce size can provide additional context about the company's scale and operations.
What is Gossamer Bio, Inc. - Common Stock EBITDA?
Gossamer Bio, Inc. - Common Stock EBITDA is -44.86 M, and its EBITDA margin is -264.59%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gossamer Bio, Inc. - Common Stock stock?
You can buy Gossamer Bio, Inc. - Common Stock (GOSS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gossamer Bio, Inc. - Common Stock stock?
Investing in Gossamer Bio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GOSS chart and related analysis on metatrader.com as part of your research.